SCHEMBL30990418

SCHEMBL30990418

Nc1ncnc2c1c(-c1noc(C3CC3)c1-c1ccccn1)nn2[C@H]1CCCNC1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 14/20 0.54
▸ KDR P35968 9/20 0.44
▸ PIK3CD O00329 6/20 0.44
▸ PIK3CA P42336 6/20 0.44
▸ PIK3CB P42338 6/20 0.44
▸ PIK3CG P48736 6/20 0.44
▸ PRKDC P78527 6/20 0.44
▸ ABL1 P00519 5/20 0.44
▸ EGFR P00533 5/20 0.44
▸ HCK P08631 5/20 0.44
▸ SRC P12931 5/20 0.44
▸ MTOR P42345 5/20 0.44
▸ EPHB4 P54760 5/20 0.44
▸ PI4KB Q9UBF8 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30990449 1.00 RET (0.54) RETKDRPIK3CDPIK3CAPIK3CB
SCHEMBL30990436 0.82 RET (0.54) RETKDREGFRSRC
SCHEMBL30990425 0.79 EGFR (0.66) RETEGFR
SCHEMBL30990430 0.79 RET (0.53) RETEGFR
SCHEMBL30990450 0.79 RET (0.51) RETKDREGFR
SCHEMBL30381942 0.78 RET (0.75) RETKDRHCK
SCHEMBL21179050 0.78 RET (0.75) RETKDRHCK
Hydrochloric Acid SCHEMBL31640040 0.78 RET (0.51) RETKDRPIK3CDPIK3CAPIK3CB
SCHEMBL14139056 0.77 BTK (0.64) KDRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30990426 0.77 RET (0.51) RETEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665720-A2 ISOINDOLINONE GLUTARIMIDE AND PHENYL GLUTARIMIDE ANALOGS AS DEGRADERS OF RET KINASE Bristol-Myers Squibb Company (US) 2025-12-24 — — EP disclosed
WO-2024173832-A2 ISOINDOLINONE GLUTARIMIDE AND PHENYL GLUTARIMIDE ANALOGS AS DEGRADERS OF RET KINASE BRISTOL-MYERS SQUIBB COMPANY (US) 2024-08-22 — — WO disclosed
Send feedback